- $2.77m
- -$5.65m
- 23
- 52
- 12
- 19
Annual balance sheet for Tharimmune, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 0.038 | 0.192 | 0.004 | 6.51 | 10.9 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 0.041 | 0.295 | 0.622 | 6.69 | 10.9 |
Total Assets | 0.041 | 0.295 | 0.622 | 6.69 | 10.9 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1.13 | 2.73 | 4.53 | 1.14 | 1.82 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 1.66 | 4.01 | 5.31 | 1.14 | 1.82 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Total Equity | -1.62 | -3.72 | -4.68 | 5.54 | 9.13 |
Total Liabilities & Shareholders' Equity | 0.041 | 0.295 | 0.622 | 6.69 | 10.9 |
Total Common Shares Outstanding |